Three different phenotypes of erythromycin-resistant streptococcus pyogenes in finland

Journal of Antimicrobial Chemotherapy

Volumn 32, Issue 6, 1993, Pages 885-891

  Seppälä, Helena ^a   Nissinen, Antti ^b   Yu, Quan ^a   Huovinen, Pentti ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Central Hospital of Middle Finland   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALOTIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; MACROLIDE; MIOKAMYCIN; PENICILLIN G; ROXITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATION; CONTROLLED STUDY; FINLAND; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; STREPTOCOCCUS PYOGENES;

ANTIBIOTICS; CLINDAMYCIN; COMPARATIVE STUDY; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; FINLAND; HUMAN; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; STREPTOCOCCUS PYOGENES; SUPPORT, NON-U.S. GOV'T;

EID: 0027717234     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/32.6.885     Document Type: Article

References (11)

1. Bisno, A. L. (1991). Group A streptococcal infections and acute rheumatic fever. New England Journal of Medicine 325, 783-93.
2. Hamilton-Miller, J. M. T. (1992). In-vitro activities of 14-, 15- and 16-membered macrolides against Gram-positive cocci. Journal of Antimicrobial Chemotherapy 29, 141-7.
3. Horodniceanu, T., Bougueleret, L. & Delbos, F. (1979). Phenotypic aspects of resistance to macrolide and related antibiotics in ^-haemolytic group A, B, C and G streptococci. In Recent Developments in Laboratory Identification Techniques (Facklam, R., Laurell, G. & Lind, I., Eds), pp. 122-31. Excerpta Medica, Amsterdam.
4. Leclercq, R. & Courvalin, P. (1991a). Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy 35, 1267-72.
5. Leclercq, R. & Courvalin, P. (1996). Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrobial Agents and Chemotherapy 35, 1273-6.
6. Miyamoto, Y., Takizawa, K., Matsushima, A., Asai, Y. & Nakatsuka, S. (1978). Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and differences in resistance pattern by type. Antimicrobial Agents and Chemotherapy 13, 399-404.
7. National Committee for Clinical Laboratory Standards (1990). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Second Edition; Approved Standard M7-A2. NCCLS, Villanova, PA.
8. National Committee for Clinical Laboratory Standards (1992). Performance Standards for Antimicrobial Susceptibility Testing; Fourth Informational Supplement MI00-S4. NCCLS, Villanova, PA.
9. Scott, R. J. D., Naidoo, J., Lightfoot, N. F. & George, R. C. (1989). A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin. Epidemiology and Infection 102, 85-91.
10. Seppala, H., Nissinen, A., Jarvinen, H., Huovinen, S., Henriksson, T., Herva, E. et at. (1992). Resistance to erythromycin in group A streptococci. New England Journal of Medicine 326, 292-7.
11. Stingemore, N., Francis, G. R. J., Toohey, M. & McGechie, D. B. (1989). The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Medical Journal of Australia 150, 626-31.